Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-06-05
2003-04-08
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S212080, C540S526000, C540S527000
Reexamination Certificate
active
06544981
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to lactam inhibitors of the enzyme Factor Xa which are useful as anticoagulants in the treatment of cardiovascular diseases associated with thromboses.
BRIEF DESCRIPTION OF THE INVENTION
In accordance with the present invention, novel lactam derivatives are provided which are inhibitors of the enzyme Factor Xa and have the structure I
including pharmaceutically acceptable salts thereof and all stereoisomers thereof, and prodrugs thereof, wherein n is an integer from 1 to 5;
R
1
, R
2
and R
3
are the same or different and are independently selected from hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, alkoxy, cyano, nitro, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, polycycloalkyl, polycycloalkylalkyl, cycloalkenyl, cycloalkynyl, alkylcarbonyl, arylcarbonyl, cycloheteroalkyl, cycloheteroalkylalkyl, cycloalkenylalkyl, polycycloalkenyl, polycycloalkenylalkyl, polycycloalkynyl, polycycloalkynylalkyl,
all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
or R
1
, R
2
and R
3
can in pairs of two join together to form a saturated carbocylic or heterocylic ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
or R
1
and R
2
can join together to form an unsaturated carbocylic or heterocylic ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
wherein R
3
is optionally a bond participating in the unsaturation of said ring;
R
4
, R
6
, R
8
, R
9
, R
a
, R
b
, are the same or different and are independently selected from hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, polycycloalkyl, polycycloalkylalkyl, cycloalkenyl, cycloalkynyl, alkylcarbonyl, arylcarbonyl, cycloheteroalkyl, cycloheteroalkylalkyl, cycloalkenylalkyl, polycycloalkenyl, polycycloalkenylalkyl, polycycloalkynyl or polycycloalkynylalkyl; all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
5
is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, alkoxyalkyl, arylalkyl, heteroarylalkyl, arylalkenyl, arylalkynyl, cycloalkyl, cycloalkylalkyl, polycycloalkyl, polycycloalkylalkyl, cycloalkenyl, cycloalkynyl, alkylcarbonyl, aminocarbonyl, substituted aminocarbonyl, arylcarbonyl, cycloheteroalkyl, cycloheteroalkylalkyl, cycloalkenylalkyl, polycycloalkenyl, polycycloalkenylalkyl, polycycloalkynyl, polycycloalkynyl-alkyl, cyano, nitro, hydroxy, amino, —OR
a
, —SR
a
, —S(O)R
a
,
all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
7
is independently selected from hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, polycycloalkyl, polycycloalkylalkyl, cycloalkenyl, cycloalkynyl, alkylcarbonyl, arylcarbonyl, cycloheteroalkyl, cycloheteroalkylalkyl, cycloalkenylalkyl, polycycloalkenyl, polycycloalkenylalkyl, polycycloalkynyl, polycycloalkynylalkyl,
all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
10
and R
10a
are the same or different are independently selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, polycycloalkyl, polycycloalkylalkyl, cycloalkenyl, cycloalkynyl, alkylcarbonyl, arylcarbonyl, cycloheteroalkyl, cycloheteroalkylalkyl, cycloalkenylalkyl, polycycloalkenyl, polycycloalkenylalkyl, polycycloalkynyl polycycloalkynylalkyl,
all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
11
and R
12
are the same or different and are independently selected from hydrogen, alkyl, aryl, cyano, nitro, heteroaryl, sulfonyl, acyl, amido, sufonamido, sulfamoyl, alkoxycarbonyl, carboxy, —C(O)
z
R
a
, —S(O)
z
R
a
,
—P(O)(OR
a
)
z
where Z is 1 or 2,
all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
c
is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, polycycloalkyl, polycycloalkylalkyl, cycloalkenyl, cycloalkynyl, cycloheteroalkyl, cycloheteroalkylalkyl, cycloalkenylalkyl, polycycloalkenyl, polycycloalkenylalkyl, polycycloalkynyl, polycycloalkynylalkyl,
all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
d
and R
e
are the same or different and are independently selected from hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, alkoxyalkyl, arylalkenyl, arylalkynyl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl, polycycloalkyl, polycycloalkylalkyl, cycloalkenyl, cycloalkynyl, alkylcarbonyl, arylcarbonyl, cycloheteroalkyl, cycloheteroalkylalkyl, cycloalkenylalkyl, polycycloalkenyl, polycycloalkenylalkyl, polycycloalkynyl, polycycloalkynylalkyl, hydroxyalkyl, alkoxycarbonyl, or aminocarbonyl; all optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
or R
d
and R
e
can be taken together with the nitrogen to which they are attached to form a cycloheteroalkyl ring or a heteroaryl ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
Z
1
, Z
2
, Z
3
, Z
4
and Z
5
are the same or different and are independently selected from hydrogen, halo, alkyl, haloalkyl, polyhaloalkyl, alkoxy, alkoxyalkyl, carboxy, carboxyalkyl, haloalkoxy, polyhaloalkoxy, alkoxycarbonyl, alkoxycarbonylalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloheteroalkyl, cycloheteroalkylalkyl, aryl, heteroaryl, arylalkyl, arylcycloalkyl, arylalkenyl, arylalkynyl, aryloxy, aryloxyalkyl, arylalkoxy, arylazo, heteroaryloxo, heteroarylalkyl, heteroarylalkenyl, heteroaryloxy, hydroxy, oxo, hydroxyalkyl, nitro, cyano, amino, substituted amino, alkylamino, dialkylamino, thiol, alkylthio, arylthio, heteroarylthio, arylthioalkyl, C(O)H, alkylcarbonyl, arylcarbonyl, amido, arylaminocarbonyl, alkoxycarbonyl, aminocarbonyl, substituted aminocarbonyl, alkynylaminocarbonyl, alkylaminocarbonyl, alkenylaminocarbonyl, alkylcarbonyloxy, arylcarbonyloxy, alkylcarbonylamino, arylcarbonylamino, alkoxycarbonylamino, arylsulfinyl, arylsulfinylalkyl, arylsulfonyl, alkylsulfonyl, aminosulfinyl, aminosulfonyl, arylsulfonylamino, heteroarylcarbonylamino, heteroarylsulfinyl, heteroarylsulfonyl, alkylsulfinyl, sulfonamido, sulfonyl, amidino, guanidino,
and wherein
R
4
and R
5
can be taken together with the nitrogen to which they are attached to form a cycloheteroalkyl ring or a heteroaryl ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
5
and R
11
can be taken together to form a heteroaryl ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
5
or R
4
or R
11
or R
12
can form a ring with R
6
which can be a cycloheteroalkyl or a heteroaryl ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
10
or R
10a
can combine with R
8
or R
9
on an adjacent carbon atom to form a saturated or unsaturated carbocyclic or heterocyclic ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
2
, Z
3
, Z
4
, and Z
5
;
R
10
and R
10a
groups on adjacent carbon atoms can combine to form a saturated or unsaturated carbocyclic or heterocyclic ring optionally substituted through available atoms with 1, 2, 3, 4 or 5 groups selected from Z
1
, Z
Li Chi
O'Connor Stephen P.
Shi Yan
Stein Philip D.
Bristol--Myers Squibb Company
Hermenau Ronald S.
Kifle Bruck
LandOfFree
Lactam inhibitors of factor Xa and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactam inhibitors of factor Xa and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactam inhibitors of factor Xa and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3002364